Shree Cement Stock Outlook: Valuation, Market Share Pressures and North Capacity Expansion

Shree Cement is trading a little above Rs 26,000 per share, making it the costliest cement stock on BSE and NSE. PL Capital has retained an ACCUMULATE stance on the large-cap stock, with a reduced target price of Rs 29,850, even though it remains more expensive than peers such as Ultratech Cement, ACC and Ambuja Cement.

PL Capital Research Analyst Tushar Chaudhari stated that Shree Cement is valued at an EV multiple of 15.6x and 13.8x based on FY27 and FY28 estimated EBITDA. The revised target price of Rs 29,850 is now based on valuing the stock at 17x EV of Sep'27E EBITDA, compared with the earlier target of Rs 31,769.

Chaudhari noted that Shree Cement’s management has reported strong traction in the non-trade segment during the past two weeks, and expects better realisations there. In contrast, demand in the trade segment has lagged earlier expectations linked to GST rationalisation benefits, and management expects any meaningful price recovery to be slow and begin from Q4FY26.

Over the next two years, more than 40mtpa of fresh cement capacity is expected to come onstream in the Northern region, which is a key market for Shree Cement. Management expects some pressure on its Northern market share, which currently stands at about 21-22 percent, while the pan-India share is nearly 9 percent, and plans to offset this through higher volumes elsewhere.

Shree Cement intends to intensify its focus on efficiency improvement across plants and aims to protect EBITDA per tonne metrics. The company is also shifting away from its year-old "value over volume" approach and is looking to drive incremental growth through higher dispatches in other regions, to compensate for any share loss in the North.

Since inception, Shree Cement has built a reputation for cost discipline and efficiency gains across operations. However, industry peers have largely adopted similar strategies over time, reducing the earlier advantage. As a result, analysts believe Shree Cement may now need to recalibrate its strategy by leaning more on inherent strengths and pursuing volume-led growth.

"Over the last few quarters, SRCM has lost market share, a cause of concern, and regaining volume momentum amid rising competitive intensity will be the key for SRCM to outperform. We cut our FY27/28E EBITDA estimates by ~4%/6% on lower pricing assumptions. The stock is trading at EV of 15.6x/13.8x of FY27/FY28E EBITDA. Maintain 'Accumulate' with revised TP of Rs29,850 (earlier Rs31,769) valuing at 17x EV of Sep'27E EBITDA.​"

For investors tracking Shree Cement, the key issues remain premium valuations, the need to regain lost market share and the impact of rising Northern capacity on pricing. The views and projections cited are those of the analyst and entities mentioned, and are provided for informational and educational use. Readers should seek guidance from licensed financial advisors before acting on any such information.